Hansa Biopharma — Januar 2026
-
Til orientering så er der lidt guf i den opdaterede pdf.
PDF'en skærper og konkretiserer timelines, adresserbare markeder, US‑kommercialiseringsplan og EMA‑roadmap på en måde, der ikke fremgik lige så detaljeret af de tidligere Q3‑rapporter og pressemeddelelser.
FX: Finansielt - runway og kapitalstruktur. Cash proforma efter 1. oktober 2025 kapitalrejsen angives til 888 MSEK (~93 mio. USD) og runway “into 2027” (ikke kun Q2 2026).
Kig selv videre ..
-
Hansa Biopharma: Navigating FDA Review and Commercial Execution:
-
Evenemang: Hansa Biopharma-presentation, J.P. Morgans 44:e årliga Healthcare-konferens
Talare: Renée Aguiar-Lucander, VD, Hansa Biopharma
Webbsändning: Webcast - 44th Annual J.P. Morgan Healthcare Conference
Tid: 10:30 PST
Datum: Onsdagen 14 januari 2026
Plats: Georgian, Weston St. Francis, San Francisco, USA
-
-
Hansa Biopharma has won the 2025 SwedenBIO Award https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-has-won-the-2025-swedenbio-award,c4296348
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind